Vandone P L, Tolva V, Trimarchi S, Rampoldi V, Giuffrida G F, Bortolani E M
Istituto di Chirurgia Generale e Cardiovascolare, Ospedale Maggiore Policlinico, Università degli Studi, Milano.
Minerva Chir. 1998 May;53(5):397-403.
In the period 1986-1994, 2950 patients with cardiovascular diseases were surgically treated. In 2104 cases we placed biological or synthetic grafts to maintain vascular continuity. The most common has turned out to be abdominal aortic aneurysm. We treated 783 cases in emergency conditions. Staging and localization of infection has been the first aim in patients with synthetic vascular grafts. We studied signs and symptoms related to infections. In all cases we discovered the microorganism responsible of infection we started antibiotic therapy.
Surgical infection incidence is 4.9% (154 cases). Series analysis has evidenced a decrease in infection incidence in the period 1986-1994. The most frequent infections are: the urinary tract infection (59 cases, 38.5%) followed by surgical wound infection (37 cases, 24.1%), respiratory tract infection (27 cases, 17.5%), vascular graft infection (23 cases, 14.4%). All patients underwent a preoperative antibiotic prophylaxis with 2 degrees-3 degrees generation cephalosporines. We noted a higher graft infection incidence in patients treated with aortobifemoral reconstruction. We handled surgical infection following two main directions: 1-antibiotic therapy, 2-surgical treatment and antibiotic therapy.
We noted surgical technique improvement and correct application of an antibiotic prophylaxis form has turned out to be the "gold standard" in order to reduce cardiovascular surgical infections. To reduce sepsis or graft infection we can work on either of the following: 1) antibiotic therapy; 2) operative time reduction; 3) try to limit vascular surgery in case of concomitant gastrointestinal surgical disease; 4) using alloplastic vascular grafts with high biological compliance; 5) patency time reduction of invasive diagnostic technique.
在1986年至1994年期间,2950例心血管疾病患者接受了外科治疗。在2104例病例中,我们植入了生物或合成移植物以维持血管连续性。最常见的情况是腹主动脉瘤。我们在紧急情况下治疗了783例病例。对于使用合成血管移植物的患者,感染的分期和定位是首要目标。我们研究了与感染相关的体征和症状。在所有病例中,一旦发现引起感染的微生物,我们就开始抗生素治疗。
手术感染发生率为4.9%(154例)。系列分析表明,1986年至1994年期间感染发生率有所下降。最常见的感染是:尿路感染(59例,38.5%),其次是手术伤口感染(37例,24.1%)、呼吸道感染(27例,17.5%)、血管移植物感染(23例,14.4%)。所有患者术前均使用二代至三代头孢菌素进行抗生素预防。我们注意到,接受主动脉双股重建治疗的患者移植物感染发生率较高。我们从两个主要方向处理手术感染:1. 抗生素治疗;2. 手术治疗及抗生素治疗。
我们注意到手术技术的改进以及正确应用抗生素预防措施已成为降低心血管手术感染的“金标准”。为了减少败血症或移植物感染,我们可以从以下方面着手:1)抗生素治疗;2)缩短手术时间;3)在伴有胃肠道外科疾病的情况下尽量限制血管手术;4)使用具有高生物相容性的异体血管移植物;5)缩短侵入性诊断技术的通畅时间。